NASDAQ:ATHE Alterity Therapeutics - ATHE Institutional Ownership Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alterity Therapeutics Limited Please log in to your account or sign up in order to add this asset to your watchlist. $2.68 -0.04 (-1.47%) (As of 03/30/2023 12:00 AM ET) Add Compare Share Share Today's Range$2.55▼$2.8450-Day Range$2.53▼$4.1552-Week Range$2.53▼$8.73Volume15,630 shsAverage Volume30,666 shsMarket Capitalization$10.75 millionP/E RatioN/ADividend YieldN/APrice Target$25.00 ProfileAnalyst RatingsChartCompetitorsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Alterity Therapeutics (NASDAQ:ATHE)CurrentInstitutional OwnershipPercentage1.69%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$291,210.11Number ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$78,693.20 Skip Chart & View Institutional Buying and Selling Data ATHE Institutional Buying and Selling by Quarter Get ATHE Insider Trade Alerts Want to know when executives and insiders are buying or selling Alterity Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Alterity Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/15/2023Millennium Management LLC96,838$34K0.0%+633.3%2.415% 2/15/2023Morgan Stanley524,364$0.18M0.0%-4.1%13.076% 2/4/2022Envestnet Asset Management Inc.82,386$59K0.0%N/A0.364% 8/13/2021Renaissance Technologies LLC237,903$0.31M0.0%+5.9%1.052% 5/21/2021Citadel Advisors LLC65,011$94K0.0%N/A0.288% 5/19/2021Virtu Financial LLC69,905$0.10M0.0%N/A0.309% 5/18/2021Morgan Stanley627,907$0.90M0.0%+7.9%2.778% 5/18/2021Citadel Advisors LLC65,011$94K0.0%N/A0.288% 5/13/2021Renaissance Technologies LLC224,690$0.32M0.0%-30.1%0.994% 2/10/2021Renaissance Technologies LLC321,500$0.43M0.0%+98.2%1.422% 11/13/2020Morgan Stanley445,978$0.90M0.0%+4.8%3.067% (Data available from 1/1/2016 forward) ATHE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ATHE shares? During the previous two years, the following institutional investors and hedge funds held shares of Alterity Therapeutics shares: Renaissance Technologies LLC ($0.31M), Morgan Stanley ($0.18M), Virtu Financial LLC ($0.10M), Citadel Advisors LLC ($94K), and Envestnet Asset Management Inc. ($59K), Millennium Management LLC ($34K).Learn more on ATHE's institutional investors. What percentage of Alterity Therapeutics stock is owned by institutional investors? 1.69% of Alterity Therapeutics stock is owned by institutional investors. Learn more on ATHE's institutional investor holdings. Which institutional investors have been buying Alterity Therapeutics stock? The following institutional investors have purchased Alterity Therapeutics stock in the last 24 months: Citadel Advisors LLC ($0.13M), Millennium Management LLC ($83.63K), Envestnet Asset Management Inc. ($82.39K), Virtu Financial LLC ($69.91K), Morgan Stanley ($45.81K), and Renaissance Technologies LLC ($13.21K). How much institutional buying is happening at Alterity Therapeutics? Institutional investors have bought a total of 424,969 shares in the last 24 months. This purchase volume represents approximately $4.59M in transactions. Which Alterity Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Alterity Therapeutics stock in the last 24 months: Renaissance Technologies LLC ($96.81K), and Morgan Stanley ($22.60K). How much institutional selling is happening at Alterity Therapeutics? Institutional investors have sold a total of 119,410 shares in the last 24 months. This volume of shares sold represents approximately $1.47M in transactions. This page (NASDAQ:ATHE) was last updated on 3/31/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.